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HEPATITIS B VIRUS INFECTION: KNOWLEDGE OF ANTENATAL 
ATTENDEES IN A TERTIARY HOSPITAL
ABSTRACT
Background: Hepatitis B virus infection constitutes a significant global health problem, and perinatal transmission 
continues to be one of the major routes of transmission in Nigeria. Having adequate knowledge about the virus and the 
available prevention strategies may lead to behavioural changes that will reduce the rate of acquisition and transmission 
of the virus. 
Objectives: To assess the knowledge about Hepatitis B virus infection among pregnant women attending antenatal booking 
clinic 
Methods: This was a cross-sectional study involving 354 pregnant women who presented for antenatal booking at Olabisi 
Onabanjo University Teaching Hospital Sagamu, Ogun State, Nigeria from 1stMay to 31st July 2018. A pretested 
questionnaire was administered to assess awareness, knowledge and attitude of pregnant women to hepatitis B virus 
infection. Statistical analysis was done using IBM-SPSS version 21 (IBM Corp, Armonk, NY, USA).  
Results: Two hundred and twenty-eight women (64.4%) were aware of Hepatitis B virus infection. One hundred and eighty-
seven women (52.8%) correctly identified hepatitis as a viral infection, while 173 (48.9%) knew that hepatitis B mainly affects 
the liver. The major source of information was health workers. More than half of the women could not correctly identify the 
mode of transmission and methods of prevention of hepatitis B virus infection. There was a significant association between 
age and educational status of the women, and knowledge of Hepatitis B virus infection (p=0.001, p=0.002 respectively).
Conclusion: This study demonstrates a knowledge deficit on Hepatitis B virus infection among pregnant women. We 
recommend that there should be a community-based health education strategy targeted at increasing the awareness and 
knowledge of hepatitis B virus infection.
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epatitis B virus is a double-stranded DNA virus 
and a member of hepadnaviridae family of 
viruses. The virus causes inflammation of the H
1liver known as hepatitis.  It is a major cause of liver-related 
morbidity and mortality and poses a significant public 
1health problem worldwide.  About 2 billion people are 
infected worldwide while 300-400 million are chronic 
carriers of the virus globally out of which 170 million cases 
1-3are in Africa.  In Nigeria, the prevalence of hepatitis B 
infection in the general population ranges between 9.3% to 
4-715.8%.  This is higher than the prevalence of 1% in 
6Western Europe, and America.  Prevalence rates of 12.2% 
and 11.2% were reported in Ghana and Kenya 
8,9respectively.
The mode of transmission of hepatitis B virus includes 
vertical transmission from mother to child, unscreened 
blood transfusion, contact with infected body fluids and 
blood, needle stick injury and unprotected sexual 
3,5intercourse with an infected partner.
Hepatitis B is a well-known carcinogen in the development 
of hepatocellular carcinoma. However, the virus is 
asymptomatic in 50% of infected cases. The clinical 
features include malaise, loss of appetite, nausea, 
vomiting, right hypochondrial pain, fever, arthralgia, 
10myalgia, jaundice and dark colour urine.  The prognostic 
spectrum includes total recovery and seronegative 
hepatitis B surface antigen (HbsAg) status, acute fulminant 
hepatitis with hepatic failure, chronic active hepatitis, 
chronic persistent hepatitis, chronic liver disease and 
hepatocellular carcinoma. Hepatitis B e antigen (HBeAg) is 
a marker for infectivity. The risk of perinatal transmission 
is about 70-90% in HBeAg positive pregnant women and 
90% of these infected children subsequently become 
11chronic carriers.  On the other hand, the risk of perinatal 
infection among infant born to HBeAg negative mothers 
ranges from 10-40% and about 40-70% of them eventually 
11,12become chronic carriers.
Vaccination is the most effective method of prevention. 
This involves passive immunization with hepatitis B 
immunoglobulin and active immunization with live 
attenuated hepatitis B virus vaccine. Immunization of 
newborn has significantly reduced the risk of vertical 
12transmission to less than 3 percent.  In addition to the 
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vaccine, adequate knowledge about the mode of 
transmission and prevention may lead to behavioural 
changes that will reduce the rate of acquisition and 
transmission of the virus. Studies have shown that while 
awareness about hepatitis may be high, the level of 
13knowledge may be low.
Hepatitis B virus screening is part of the routine antenatal 
booking investigation in our facility; however, no study 
has been done to access the awareness and knowledge of 
hepatitis B virus infection in pregnancy. Hence this study is 
designed to access the awareness and knowledge of 
hepatitis B virus infection among pregnant women. The 
outcome of the study will serve as a basis for comparison 
with other studies done in other tertiary institutions and 
future studies on hepatitis B in our facility.    
Materials and methods
This study was carried out at Olabisi Onabanjo University 
Teaching Hospital Sagamu, Ogun State, Nigeria. It was a 
cross-sectional study of pregnant women presenting at 
antenatal booking clinic from 1st May to 31st July 2018. The 
minimum sample size for this study was calculated using 
14the Leslie-Kish formula . Using a prevalence of 71.5% from 
13,a previous study  the calculated minimum sample size 
was 313. However, to allow for attrition, a sample size of 
354 was used for the study. The women were recruited 
consecutively until the required sample size was reached. 
A structured questionnaire was used for the survey among 
women at first contact in the antenatal booking clinic 
before health education by medical personnel. Most of the 
questions were closed-ended. The questionnaire was 
pretested at the antenatal clinic and administered by 
trained research assistants. Information obtained included 
awareness of hepatitis B virus infection, knowledge of the 
mode of transmission and methods of prevention, attitude 
to hepatitis B virus infection and the sources of information 
about hepatitis B virus infection. Women who had 
previously heard of hepatitis B virus infection were 
classified as being aware. The attitude to hepatitis B virus 
infection was assessed in terms of the willingness of the 
women to accept treatment if tested positive, and the 
willingness to let their babies receive hepatitis B 
immunoglobulin when indicated. Ethical approval for the 
study was obtained from the Health Research Ethics 
Committee of Olabisi Onabanjo University Teaching 
Hospital (reference number OOUTH/HREC/229/2018). 
The research was conducted in accordance with the World 
Medical Association Declaration of Helsinki. All study 
participants were given full information on all aspects of 
the study and then asked to sign an informed consent form. 
The study participants were assured of the confidentiality 
of data obtained from them. The data were entered into 
IBM-SPSS version 21 (IBM Corp, Armonk, NY, USA). 
Continuous variables were summarized using means. 
Categorical variables were summarized using frequencies 
and percentages. Chi-square was used to determine 
relationships between categorical variables. A p-value less 
than 0.05 was considered as statistically significant.
Results 
The socio-demographic characteristics of the study 
participants are shown in table i. The mean age of the study 
population was 29.4±4.1 years with a range of 19-
43years.The age group 21-30 years accounted for the 
majority (51.1%) of the women. The parity range was 0 - 6, 
majority 149(42.1%) of the respondents were within parity 
group 1-2, while grandmultiparas were the least 41(11.6%). 
The educational status of the study population revealed 
that 58(16.4%) pregnant women did not have any formal 
education, 47(13.3%) completed primary school, 
143(40.4%) completed secondary school while 106 (30.0%) 
had tertiary education.
Out of the total sample size of 354, about 228 (64.4%) of the 
pregnant women surveyed were aware of hepatitis B virus 
infection. One hundred and eighty-seven women (52.8%) 
knew that hepatitis B is a viral infection, while 173 (48.9%) 
knew that hepatitis B mainly affects the liver. More than 
half of the women could not correctly identify the mode of 
transmission and the methods of prevention of hepatitis B 
virus infection (table ii).
The major sources of information about hepatitis B virus 
infection were health professionals 78(22.0%), school 
teachers 43(12.1%) and through radio and television 
38(10.7%). Only 96(27.1%) women had been previously 
screened for the infection (table iii).
One hundred and five women (29.7%) were willing to let 
their babies receive hepatitis B vaccine if found positive 
while 109 women (30.8%) were willing to accept 
medications for treatment if tested positive.
Table iv depicts the association between knowledge of 
hepatitis B virus infection and socio-demographic status of 
respondents. There was a statistically significant 
association between the awareness of hepatitis B virus 
2 infection and age group (x = 27.4579, P<0.001). Similarly, 
there was a statistically significant association between the 
awareness of hepatitis B virus infection and educational 
2status of respondents (x =0.2821, P=0.003). There was no 
significant association between parity and awareness of 
2 hepatitis B virus infection (x = 14.2885, P=0.963).
Discussion 
This study was designed to assess the baseline knowledge 
about Hepatitis B virus infection among pregnant women 
who presented for antenatal booking at a tertiary hospital. 
Out of the 354 pregnant women that participated in the 
study 64.4% were aware of hepatitis B virus infection, 
which was similar to 71.5% reported in Abakaliki but 
13,15higher than 5% found in a study in India.  Among the 
women who had awareness about the infection, the level of 
knowledge on the mode of transmission and methods of 
prevention was generally poor; only about half of the 
respondents knew that the virus mainly affects the liver. 
13Similar findings were reported in Abakaliki, Ebonyi state.  
It was observed that 47.4% of the respondents were aware 
of mother to child transmission of hepatitis B virus; this 
16was lower than 83.3% reported in Benue.  This is expected 
as the latter study was conducted among members of staff 
and students of an academic institution where 90% of them 
had a tertiary level of education. Furthermore, only 30.8% 
of the respondents knew that HBV could be transmitted 
through sexual intercourse; this value is lower than 47% 
5reported among antenatal women in Enugu.  This is 
alarming and indicates an urgent need for extensive health 
education with a specific target on the role of risky sexual 
behaviour in the transmission of the virus. 
Only one-quarter of the women had been previously 
25
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screened for hepatitis B virus infection. However, majority 
of the respondents who were aware of hepatitis B virus 
infection were willing to be screened. This underscores the 
importance of health education in promoting appropriate 
health-seeking behaviour. Thirty percent of respondents 
indicated the desire to take antiviral medications to 
prevent mother to child transmission of the virus, and also 
subsequently for their own treatment. A lower value of 
1711.7% was reported from a survey done in China.  The 
perceived absence of appropriate guidelines and lack of 
supporting evidence to support either safety or efficacy 
may be responsible for the generally low desire for the use 
of antiviral drugs by hepatitis B virus-positive pregnant 
17women.
Administration of hepatitis B vaccine is a safe and effective 
prevention strategy against hepatitis B virus infection. In 
this study, only 37.8% of the participants knew that 
hepatitis B infection could be prevented by immunization 
with hepatitis B vaccine. Fortunately, active immunization 
with hepatitis B vaccine is currently part of the childhood 
immunization schedule in Nigeria. This might help in 
reducing the prevalence of hepatitis B virus seropositivity. 
Passive immunization with hepatitis B immunoglobulin is 
also recommended for hepatitis exposed neonates. 
However, only a third of the respondents indicated the 
willingness to allow their babies to receive hepatitis 
immunoglobulin at birth when indicated. This may be due 
to lack of awareness, and the cost implication, which is 
often beyond the reach of many women. Effort should be 
made to counsel hepatitis B virus-positive women on the 
need for passive immunization of their babies. It is also 
desirable that the government should subsidize the cost of 
this immune globulin so that many women could have 
access to it. The major source of information about hepatitis 
B virus infection was health workers. This is contrary to 
findings from a study done in Ghana, where mass media 
18was the most important source of information.
The age of the respondents had a statistically significant 
association with an awareness of hepatitis B virus 
infection. Women within the age group of 21-30 years 
demonstrated an encouraging level of awareness 
compared to other age groups.  This might be because the 
age range represents the peak of reproductive age and such 
women were likely better informed about pregnancy-
19related health conditions . Also, the educational status of 
study participants had a statistically significant association 
with the level of awareness of hepatitis B virus infection. 
This underscores the importance of formal education in 
health promotion. The parity of respondents had no 
significant association with the awareness of hepatitis B 
virus infection; this is despite the fact that a sizeable 
proportion of the study participants were multiparous and 
would likely have received some education about hepatitis 
B virus infection as part of antenatal counselling in 
previous pregnancies. This indicates the need for more 
effective antenatal health education sessions. 
This study revealed a suboptimal level of knowledge and 
awareness about hepatitis B virus infection among 
pregnant women. Health education and promotion 
targeted at improving awareness and knowledge of 
hepatitis B virus infection among women of reproductive 
age is essential. Improved knowledge of hepatitis B 
infection will likely lead to behavioural changes that will 
ultimately result in a reduction in mother to child 
transmission of hepatitis, and also the associated maternal 
morbidity and mortality. 
Conclusion
The knowledge of Hepatitis B viral infection among the 
respondent is suboptimal. We recommend that there 
should be a community-based health education strategy 
targeted at increasing the awareness and knowledge of 
hepatitis B. Also, efforts should be channelled at increasing 
the coverage of hepatitis B immunization and promoting 
the use of hepatitis B immune globulin by babies of 
hepatitis B virus-positive mothers. This will help to reduce 
the prevalence of hepatitis B virus infection and 
subsequently, the rate of mother-to-child transmission.
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Table i: Socio-demographic characteristics of the study participants
 




















































Secondary  143 40.4 
Tertiary 106 30.0 
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Table ii: knowledge on mode of transmission and methods of prevention of Hepatitis B virus infection  
Knowledge  
 
Yes (%) No (%) Don’t know (%)  
Mode of transmission    
Unscreened blood transfusion 152 (42.9) 24 (6.8)  52(14.7) 
Unprotected sexual intercourse 108 (30.5) 92 (26.0) 28(7.9) 
Sharing of sharp objects 93 (26.3) 73 (20.6) 62(17.5) 
Mother to child transmission 168 (47.4) 47 (13.3) 13(3.7) 
Contaminated food / Water   87 (24.6) 103 (29.1) 38(10.7) 
Mosquito bite  64 (18.1) 123 (34.7) 41(11.6) 
Air-borne 71 (20.1) 107 (30.2) 50(14.1) 
Method of prevention    
Immunization   134 (37.9) 63 (17.8) 31(8.7) 
Safe blood transfusion  129 (6.4) 59 (16.7) 40(11.3) 
Improved personal hygiene 104 (29.4) 80 (22.6) 44(12.4) 
Avoid multiple sexual partner 168 (47.5) 23 (6.5)  37(10.4) 
Avoid sharing of sharp objects 113 (32.0) 61 (17.2) 54(15.2) 
Good food hygiene 173 (48.9) 34 (9.6)  21(5.9) 
* A total of 126 women were not aware of Hepatitis B virus infection **The total sample size of 354 was used as 
denominator in calculating proportions. 
Table iii: Sources of information to participants who are aware of hepatitis B virus infection 
Medium Frequency  % 
Radio / Television 38 10.7 
School teacher  43 12.2 
Health worker   78 22.0 
Books   36 10.2 
Newspaper 22 6.2 
Church / mosque 11 3.1 
Total  228 64.4 
* A total of 126 women were not aware of Hepatitis B virus infection **The total sample size of 354 was used as 
denominator in calculating proportions 
 







Age     
<20 2(33.3) 6(66.7)      27.4579 <0.001* 
21-30 139(76.8) 42(23.2)   
31-40 64(59.3) 59(40.7)   
>40 23(54.8) 19(45.2)   
Parity     
0 51(65.4) 27(34.6) 0.2821 0.963 
1-2 97(65.1) 52(34.9)   
3-4 55(67.9) 31(32.1)   
>5 25(61.0) 16(39.0)   
Educational status     
Informal  35(60.3) 23(39.7) 14.2885 0.003* 
Primary  22(46.8) 25(53.2)   
Secondary  107(72.8) 36(27.2)   
Tertiary  64(60.4) 42(39.6)   
*P<0.05 is statistically significant 
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